GlassScriptPhysician profile
Nathan Punwani
NPI 1053751800
$1,075.93
in general payments reported to CMS, 2019-2025
8 companies · $17.50 in 2025
The $17.50 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2021: $22.99 · 2023: $537 · 2025: $17.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500 · Education: $37.21 · Food and Beverage: $17.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
| Education | $37.21 |
| Food and Beverage | $17.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $500.00 | 2023 | |
| Abbvie INC. | $179.48 | 2019-2025 | |
| Amgen INC. | $158.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.07 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $37.21 | 2023 | Abecma |
| Spectrum Pharmaceuticals INC. | $22.05 | 2019 | |
| Kyowa Kirin, INC. | $17.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Punwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.